Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

Peripheral artery disease (PAD) is a major cause of morbidity and mortality but it is usually underdiagnosed and undertreated. Patients with PAD present dysregulated procoagulant, anticoagulant, and fibrinolytic pathways leading to arterial and venous thrombosis. The risk of several ischemic-related...

Full description

Bibliographic Details
Main Authors: José Miguel Rivera-Caravaca, Anny Camelo-Castillo, Inmaculada Ramírez-Macías, Pablo Gil-Pérez, Cecilia López-García, María Asunción Esteve-Pastor, Esteban Orenes-Piñero, Antonio Tello-Montoliu, Francisco Marín
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
peripheral artery disease
anticoagulation therapy
rivaroxaban
antiplatelet therapy
Online Access:https://www.mdpi.com/1422-0067/22/13/7113

Internet

https://www.mdpi.com/1422-0067/22/13/7113

Similar Items